CALL US: 206.533.3854
CALL US  206.533.3854
AEON Law logo full color transparent
By آرمین - Own work, Public Domain, https://commons.wikimedia.org/w/index.php?curid=26834387

Supreme Court Rules that Patent Judge’s Decisions Must be Reviewed by Director

US Supreme Court:
Judges not “inferior,”
Director reviews

The US Supreme Court has ruled that the US Patent Office Administrative Patent Judges (APJs) are not “inferior” officers in the context of inter partes reviews (IPR) in violation of the Constitution.

However, rather than finding the entire IPR system unconstitutional, the Court held that the problem can be fixed by making the AJP’s decisions subject to review by the Director of the United States Patent and Trademark Office (USPTO).

The case of the United States v. Arthrex arose when Smith & Nephew, Inc., sought IPR of Arthrex, Inc.’s patent for a “surgical device for reattaching soft tissue to bone without tying a knot.” Arthrex had previously sued Smith for patent infringement.

Three AJPs of the Patent Trial and Appeal Board (PTAB) concluded Arthrex’s patent was invalid. Arthrex then appealed to the Federal Circuit, arguing that the whole IPR system was Invalid under the US Constitution.

The IPR procedure was enacted in 2012 as part of the America Invents Act and is used to challenge the patentability of one or more claims in a patent.

As the Court explains,

inter partes review is an adversarial process by which members of the PTAB reconsider whether existing patents satisfy the novelty and non-obviousness requirements for inventions.

The IPR procedure is conducted by the PTAB. As the Court notes,

The PTAB sits in panels of at least three members drawn from the Director, the Deputy Director, the Commissioner for Patents, the Commissioner for Trademarks, and more than 200 Administrative Patent Judges (APJs).

On appeal, Arthrex raised an argument based on the Appointments Clause of the US Constitution. This clause provides:

[The President] shall nominate, and by and with the Advice and Consent of the Senate, shall appoint Ambassadors, other public Ministers and Consuls, Judges of the Supreme Court, and all other Officers of the United States, whose Appointments are not herein otherwise provided for, and which shall be established by Law: but Congress may by Law vest the Appointment of such inferior Officers, as they think proper, in the President alone, in the Courts of Law, or in the Heads of Departments

As the Court explains,

That Clause specifies how the President may appoint officers who assist him in carrying out his responsibilities. Principal officers must be appointed by the President with the advice and consent of the Senate, while inferior officers may be appointed by the President alone, the head of an executive department, or a court. Art. II, §2, cl. 2. Arthrex argued that the APJs were principal officers and therefore that their appointment by the Secretary of Commerce was unconstitutional.

The clause is intended to promote accountability:

Assigning the nomination power to the President guarantees accountability for the appointees’ actions because the “blame of a bad nomination would fall upon the President singly and absolutely.”

As Alexander Hamilton wrote,

the sole and undivided responsibility of one man will naturally beget a livelier sense of duty and more exact regard to reputation.

The Court noted that

Congress provided that APJs would be appointed as inferior officers, by the Secretary of Commerce as head of a department. The question presented is whether the nature of their responsibilities is consistent with their method of appointment.

The US Government intervened in the private dispute to defend its appointment procedure.

The Court concluded:

We hold that the unreviewable authority wielded by APJs during inter partes review is incompatible with their appointment by the Secretary to an inferior office.

However, the Court resisted throwing out the whole IPR system:

In general, “when confronting a constitutional flaw in a statute, we try to limit the solution to the problem” by disregarding the “problematic portions while leaving the remainder intact.”

Thus, held the Court, “Decisions by APJs must be subject to review by the Director.”

The Court then remanded the case to the Acting Director of the USPTO.

The Court clarified:

the Director need not review every decision of the PTAB. What matters is that the Director has the discretion to review decisions rendered by APJs. In this way, the President remains responsible for the exercise of executive power—and through him, the exercise of executive power remains accountable to the people.


Just like the haiku above, we like to keep our posts short and sweet. Hopefully, you found this bite-sized information helpful. If you would like more information, please do not hesitate to contact us here.

Related Articles

Federal Circuit Finds No Motive to Combine in Laser Projector Patent Case

The Federal Circuit has reversed a finding by the Patent Trial and Appeal Board (PTAB or Board) that certain challenged claims of a patent for ...
Read More

Federal Circuit Affirms Blockchain Gem Patent Is Invalid

The Federal Circuit has affirmed a lower court’s decision finding the claims of a patent for preventing gemstone counterfeiting invalid. The case is Rady v. ...
Read More

Tennessee Passes Law Against AI Voice Copies

The state of Tennessee has passed a law against the use of artificial intelligence (AI) to copy a person’s voice. The law, signed on March ...
Read More

Let's work together.

Contact us to set up a meeting with an attorney or team member.

Stay Informed

Sign up to receive Patent Poetry—a monthly roundup of key IP issues in our signature haiku format. Four articles (only 68 syllables); zero hassle.

SECTORS

HIGH
TECHNOLOGY

Artificial Intelligence

Blockchain & Cryptocurrency

Computer Technology & Software

Consumer Electronics

Electrical Devices

MECHANICAL
& PRODUCTS​

Cleantech

Mechanical Devices

Consumer & Retail Products

Hardware & Tools

Toys & Games

LIFE SCIENCES
& CHEMISTRY​

Biotechnology

Chemical Compounds

Digital Health

Healthcare Products

Pharmaceuticals

BRANDING
& CREATIVE​

Books & Publications

Brand Creation

Luxury Products

Photography & Video

Product Design

SERVICES

PROTECT

DEAL

DEFEND